Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 13/20 | 0.71 |
| ▸ | GCGR | P47871 | 3/20 | 0.71 |
| ▸ | CALCA | P06881 | 2/20 | 0.68 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.67 |
| ▸ | NPY1R | P25929 | 1/20 | 0.66 |
| ▸ | NPY2R | P49146 | 1/20 | 0.66 |
| ▸ | NPY4R | P50391 | 1/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.66 |
| ▸ | NMBR | P28336 | 1/20 | 0.62 |
| ▸ | GRPR | P30550 | 1/20 | 0.62 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.62 |
| ▸ | CCKBR | P32239 | 2/20 | 0.62 |
| ▸ | GIPR | P48546 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30932197 | 1.00 | GLP1R (0.71) | GLP1RGCGRCALCAC5AR1NPY1R | |
| Galanin SCHEMBL29352997 | 0.94 | GLP1R (0.67) | GLP1RGCGRCALCANPY1RNPY2R | |
| SCHEMBL30495753 | 0.94 | NPY1R (0.70) | GLP1RGCGRCALCAC5AR1NPY1R | |
| SCHEMBL30066026 | 0.93 | GLP1R (0.63) | GLP1RGCGRCALCAC5AR1NPY1R | |
| SCHEMBL30598153 | 0.92 | NPY1R (0.70) | GLP1RGCGRNPY1RNPY2RNPY4R | |
| SCHEMBL30598171 | 0.91 | GLP1R (0.71) | GLP1RGCGRNPY1RNPY2RNPY4R | |
| SCHEMBL30598183 | 0.91 | NPY1R (0.70) | GLP1RGCGRNPY1RNPY2RNPY4R | |
| SCHEMBL30598194 | 0.91 | NPY1R (0.71) | GLP1RGCGRNPY1RNPY2RNPY4R | |
| SCHEMBL31060386 | 0.91 | CALCA (0.75) | GLP1RGCGRCALCANPY1RNPY2R | |
| SCHEMBL29638062 | 0.90 | GLP1R (0.74) | GLP1RGCGRC5AR1NPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116751261-A | GALR2 agonist and application thereof | 湖南中晟全肽生化有限公司 | 2023-09-15 | — | — | CN | disclosed |